STOCK TITAN

AETERNUM HEALTH INC SEC Filings

AETN OTC Link

Welcome to our dedicated page for AETERNUM HEALTH SEC filings (Ticker: AETN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AETERNUM HEALTH's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AETERNUM HEALTH's regulatory disclosures and financial reporting.

Rhea-AI Summary

Aeternum Health, Inc. (formerly Shorepower Technologies) reports a sharp downturn in operations and prepares a major business pivot. Q1 2026 revenue fell to $2,260 from $164,657 a year earlier, producing a negative gross margin of $11,977 and a net loss of $139,655 after prior-year net income.

At March 31, 2026, the company held cash of $19,156, had a working capital deficit of $1,158,363, total liabilities of $2,137,041, and an accumulated deficit of $3,417,796, leading management to disclose substantial doubt about its ability to continue as a going concern. Operations are being funded through related-party loans and small equity raises.

The company has signed a merger agreement with Aeternum Health LLC under which it will divest its transportation electrification business and refocus on longevity and anti‑aging healthcare. Aeternum will contribute at least $1.5 million in cash plus intellectual property, while Paul Mann will receive 51% of the common equity and 2,000,000 Series B preferred shares with super‑voting rights. Existing CEO Jeff Kim has agreed to cancel up to 13,000,000 common shares, and authorized common stock has been increased from 100,000,000 to 250,000,000 to support the transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Summary

ShorePower Technologies Inc. notified the SEC it cannot timely file its Form 10-Q for the quarter ended March 31, 2026.

The company states it needs additional time to compile and analyze supporting documentation and to allow its independent registered public accounting firm to complete its review; it intends to file the Form 10-Q as soon as possible.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many AETERNUM HEALTH (AETN) SEC filings are available on StockTitan?

StockTitan tracks 2 SEC filings for AETERNUM HEALTH (AETN), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AETERNUM HEALTH (AETN)?

The most recent SEC filing for AETERNUM HEALTH (AETN) was filed on May 19, 2026.